The Safety, Tolerability, and Analgesic Efficacy of Delta9-THC (Namisol) in Chronic Pancreatitis Patients Suffering From Persistent Abdominal Pain.

Trial Profile

The Safety, Tolerability, and Analgesic Efficacy of Delta9-THC (Namisol) in Chronic Pancreatitis Patients Suffering From Persistent Abdominal Pain.

Completed
Phase of Trial: Phase II

Latest Information Update: 23 May 2014

At a glance

  • Drugs Dronabinol (Primary) ; Diazepam
  • Indications Abdominal pain
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 May 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 24 Oct 2012 Additional lead trial centre identified as reported by European Clinical Trials Database.
    • 15 Feb 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top